339 related articles for article (PubMed ID: 10502440)
1. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
2. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
[TBL] [Abstract][Full Text] [Related]
3. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
4. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
Cohen I
Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
[TBL] [Abstract][Full Text] [Related]
5. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
7. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic endometrial megapolyps in women with breast carcinoma.
Berezowsky J; Chalvardjian A; Murray D
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
10. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
Tate S; Yamazawa K; Sekiya S
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):769-70. PubMed ID: 15255851
[No Abstract] [Full Text] [Related]
13. [Tamoxifen and giant endometrial polyps].
Caschetto S; Cassaro N; Consalvo P; Caragliano L
Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
Epifani S; Lattarulo S; Maiorino R; Fabiano G
G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
[TBL] [Abstract][Full Text] [Related]
15. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
[TBL] [Abstract][Full Text] [Related]
16. [Endometrial cancers arising in polyps associated with tamoxifen use].
Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
[TBL] [Abstract][Full Text] [Related]
17. Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA; Johnson J; Weed JC
Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
[TBL] [Abstract][Full Text] [Related]
18. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy.
Markovitch O; Tepper R; Fishman A; Aviram R; Cohen I
Maturitas; 2008 Apr; 59(4):387-93. PubMed ID: 18490117
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
